PepperLedger
COMPOUND LIBRARY·UROLITHIN A
COMPOUND PROFILE · PEPPERLEDGER

Urolithin A

Type
3,8-Dihydroxy-6H-dibenzo[b,d]pyran-6-one — a gut microbiome-derived metabolite of ellagitannins (pomegranates, walnuts, berries)
Class
Mitophagy inducer · Mitochondrial quality control activator
Administration
Oral supplement (e.g. Mitopure by Timeline) — daily
Half-life
Not a primary clinical parameter for this compound class
Most studied use
Mitophagy and mitochondrial quality control · Muscle function and endurance · Longevity
Regulatory status
FDA Generally Recognized as Safe (GRAS) as a food ingredient · No approved drug indication · Available as a premium supplement
Human evidence
Strong for a supplement — Phase I safety confirmed; Phase II RCT showing improved muscle function and endurance in older adults
Preclinical evidence
Exceptional — lifespan extension in worms and flies, muscle improvement in aged mice, mitophagy induction across multiple models

EDUCATIONAL TOOL — NOT MEDICAL ADVICE

What is Urolithin A?

Urolithin A is one of the most exciting natural compounds in the longevity space — and one of the few with genuine Phase II human RCT data showing improvements in physical performance. It's produced when gut bacteria metabolize ellagitannins — polyphenolic compounds found in pomegranates, walnuts, and certain berries. The problem: only about 30–40% of people have the right gut microbiome composition to produce meaningful amounts of Urolithin A from dietary sources. Everyone else produces little or none, regardless of how much pomegranate they eat. This is why supplemental Urolithin A exists.

Urolithin A's primary mechanism is mitophagy induction — the cellular process that selectively removes damaged, dysfunctional mitochondria. Mitophagy is to mitochondria what autophagy is to the cell broadly: a quality control mechanism that clears out damaged components before they impair function. As cells age, mitophagy declines — damaged mitochondria accumulate, cellular energy production becomes less efficient, and ROS production increases. Urolithin A activates mitophagy via PINK1/Parkin signaling, accelerating the removal of dysfunctional mitochondria and improving the quality of the remaining mitochondrial pool.

The human evidence from Timeline's clinical program is meaningful. A Phase II RCT in older adults (65–90) showed Urolithin A (Mitopure, 1000 mg/day, 4 months) significantly improved 6-minute walk distance, muscle strength (handgrip, leg press), and mitochondrial gene expression vs. placebo. Muscle biopsies showed increased mitochondrial biogenesis and reduced mitochondrial stress markers. For a supplement compound (not a drug), this is unusually rigorous evidence.

Urolithin A fits neatly into the mitochondrial longevity stack alongside MOTS-c (AMPK activation and metabolic signaling), SS-31 (inner mitochondrial membrane protection), and NAD+ (fuel for mitochondrial enzymes). Where those compounds address mitochondrial function and protection, Urolithin A specifically addresses mitochondrial quality — clearing out the damaged mitochondria that impair the function of the healthy ones.

How it works

Mitophagy — Clearing Damaged Mitochondria

Mitophagy is selective autophagy targeting damaged mitochondria. The primary pathway: damaged mitochondria lose their membrane potential → PINK1 kinase accumulates on the outer mitochondrial membrane (normally imported and degraded) → PINK1 phosphorylates and recruits Parkin E3 ubiquitin ligase → Parkin ubiquitinates outer mitochondrial membrane proteins → ubiquitin-binding autophagy receptors (p62, NDP52, OPTN) recruit the autophagosome → the damaged mitochondrion is engulfed and degraded. Urolithin A activates this PINK1/Parkin pathway, specifically increasing the rate at which damaged mitochondria are identified and cleared.

Mitochondrial Biogenesis — The Follow-Up

Removing damaged mitochondria triggers compensatory mitochondrial biogenesis via PGC-1α — the master regulator of mitochondrial gene expression. The net effect of Urolithin A: fewer damaged mitochondria plus more newly synthesized healthy mitochondria equals higher average mitochondrial quality, better electron transport chain efficiency, reduced ROS, and improved cellular energy production. This improvement in mitochondrial pool quality is the basis for the muscle function improvements seen in human trials.

Why Gut Microbiome Dependence Matters

Ellagitannins — the dietary precursors in pomegranates and walnuts — must be converted to Urolithin A by specific gut bacteria, primarily Gordonibacter pamelaeae and Ellagibacter isourolithinifaciens. These bacteria are not present in all people and their abundance varies significantly. Studies show only 30–40% of people are "converters" who produce meaningful Urolithin A from dietary ellagitannins. Supplemental Urolithin A bypasses this variability — providing the bioactive compound directly regardless of microbiome status.

Lifespan Extension in Model Organisms

Urolithin A extends lifespan in C. elegans (worms) by 45% and in Drosophila (fruit flies). In aged mice, it improves muscle function and endurance comparable to exercise training effects in sedentary animals. The mitophagy mechanism is consistent across species — which is why it's taken seriously as a candidate longevity intervention in humans.

What the research shows

HUMAN EVIDENCE
STUDYJAMA Network Open · 2022

Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: a randomized clinical trial

Liu S, D'Amico D, Shankland E et al.

88 adults aged 65–90. Mitopure (Urolithin A) 500 or 1000 mg/day vs. placebo for 4 months. Significant improvements in 6-minute walk distance, handgrip strength, and leg press vs. placebo at 1000 mg. Muscle biopsies showed increased mitochondrial biogenesis and reduced mitochondrial dysfunction markers — the most compelling human evidence for Urolithin A.

View on PubMed →
STUDYNature Metabolism · 2019

The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans

Andreux PA, Blanco-Bose W, Ryu D et al.

60 healthy adults, dose-escalation safety trial. Mitopure was safe and well-tolerated at all doses. Muscle biopsies confirmed mitophagy gene activation (PINK1, Parkin, LC3) at 500 and 1000 mg — the first human evidence that oral Urolithin A actually induces mitophagy in human muscle tissue.

View on PubMed →
STUDYNature Medicine · 2016

Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents

Ryu D, Mouchiroud L, Andreux PA et al.

Foundational paper establishing Urolithin A's mitophagy mechanism, lifespan extension in C. elegans, and muscle function improvements in rodent models — the basis for the entire Urolithin A research program.

View on PubMed →
WHAT THE RESEARCH SHOWS
KNOWN
  • Mitophagy induction in human skeletal muscle, confirmed via Phase I biopsy data
  • Improved muscle function and endurance in an elderly RCT
  • Safe and well-tolerated at 500–1000 mg
  • Lifespan extension in worms and flies
  • Gut microbiome-independent when supplemented directly
?UNCERTAIN
  • ?Human lifespan or healthspan extension (no longevity RCT)
  • ?Effects in younger, healthy adults vs. elderly populations
  • ?Optimal dose for longevity vs. performance goals
  • ?Long-term effects beyond the 4-month trial duration
  • ?Whether combining with other mitochondrial compounds is additive or redundant

What the community reports

Urolithin A has the most mainstream-accessible community of any compound in the mitochondrial longevity space — Timeline's Mitopure branding has brought it to a broader wellness audience beyond the hardcore biohacker space. The evidence quality relative to other longevity supplements is genuinely superior.

Improved energy and endurance — the most consistently reported effect, consistent with the mitochondrial quality improvement mechanism
Muscle recovery improvement — reduced soreness after training, faster readiness for the next session
Less immediate-feeling than compounds like NAD+ IV or rapamycin — the mitophagy mechanism is slow and structural; effects build over weeks, not days
The Timeline (Mitopure) brand is the only standardized Urolithin A product with clinical trial backing — generic Urolithin A supplements may have variable bioavailability, and the community generally recommends the standardized product for reproducible results
Often stacked with the broader mitochondrial longevity protocol — MOTS-c + NAD+ + SS-31 + Urolithin A — each addressing a different aspect of mitochondrial health

THE MITOCHONDRIAL LONGEVITY STACK

Urolithin A: mitophagy — removes damaged mitochondria (quality control). MOTS-c: AMPK activation, metabolic efficiency, exercise mimetic (signaling). SS-31: inner mitochondrial membrane protection, ETC stabilization (structural). NAD+ (NMN/NR): sirtuin activation, fuel for mitochondrial enzymes (fuel supply). Each compound addresses a different layer of mitochondrial health — Urolithin A's mitophagy is the quality control layer, most complementary to the others when the pool of mitochondria being protected, fueled, and signaled are the high-quality ones that remain after Urolithin A has cleared the damaged ones.

Common misconceptions

"Eating pomegranates achieves the same result."

REALITY

60–70% of people cannot produce meaningful Urolithin A from dietary ellagitannins due to lacking the required gut bacteria. Even in converters, the amounts produced are inconsistent. Supplemental Urolithin A provides a standardized dose independent of microbiome status.

"Urolithin A is just another antioxidant supplement."

REALITY

Urolithin A's primary mechanism is mitophagy induction — selectively removing damaged mitochondria. This is a fundamentally different mechanism from antioxidant supplementation, which neutralizes ROS but doesn't clear the damaged mitochondria generating them. Urolithin A addresses the root cause (damaged mitochondria) rather than the symptom (ROS).

"The effects are immediate."

REALITY

Mitophagy is a slow, structural cellular process. The Phase II RCT showed improvements at 4 months — not weeks. Users who expect immediate effects like those from NAD+ IV will be disappointed. Urolithin A is a long-timeline intervention requiring consistent daily supplementation for months to show measurable results.

AI COACH PREVIEW
I'm building a mitochondrial longevity stack and want to add Urolithin A. How does it fit with MOTS-c and NAD+?
They're genuinely complementary rather than redundant, because each one operates on a different layer of mitochondrial biology. Urolithin A's job is quality control - it triggers mitophagy (PINK1/Parkin) to clear out damaged mitochondria, then mitochondrial biogenesis (PGC-1alpha) replaces them with new ones. NAD+ is fuel supply - it's the substrate sirtuins and the electron transport chain need to function, regardless of how 'clean' your mitochondrial pool is. MOTS-c sits more on the signaling side - AMPK activation and metabolic efficiency, somewhat exercise-mimetic. The sequencing logic some practitioners use: Urolithin A's clearance-and-renewal cycle takes about 4 months to show measurable effects (that's the RCT timeline), so it's a long-run addition rather than something you'll feel quickly. NAD+ effects are often more immediate (energy, cognition) because you're directly addressing a fuel bottleneck. My suggestion: if budget or pill burden is a constraint, Urolithin A (1000mg/day, ideally the Mitopure/Timeline standardized form since generic UA bioavailability varies) is the one with the strongest human RCT behind it for muscle function specifically - it's a reasonable anchor to add first, then layer in NAD+ or MOTS-c based on what outcome you're prioritizing (energy/cognition vs. metabolic efficiency).
CONTINUE IN THE APP

Open PepperLedger to track your Urolithin A protocol →

Free to join. No credit card. Ask the Coach how Urolithin A fits your mitochondrial stack.

Free to join · No credit card · 23-day Pro trial included